Elizabeth Dianne Pulte

5PUBLICATIONS
23CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsFood properties (incl. characteristics and health benefits)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 30, 2026
Real-World Treatment Patterns and Outcomes Among Patients With Newly Diagnosed AML in the United States.

|Jul 01, 2025
FDA Approval Summary: Ivosidenib for Treatment of Adult Patients with Relapsed/Refractory Myelodysplastic Syndrome with an IDH1 Mutation.

Ashley C Woods, E Dianne Pulte, Xin Wang

|May 17, 2019
Changes in population-level survival for advanced solid malignancies with new treatment options in the second decade of the 21st century.

Dianne Pulte, Janick Weberpals, Lina Jansen

|Apr 26, 2019
U.S. Food and Drug Administration Benefit-Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Remission.

E Dianne Pulte, Tanya Wroblewski, Erik Bloomquist

|Jan 25, 2018
Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications.

E Dianne Pulte, Lei Nie, Nicole Gormley

Pageof 1

Frequent Collaborators

2 joint publications

Richard Pazdur

2 joint publications

Jonathon Vallejo

2 joint publications

Kelly Norsworthy

2 joint publications

R Angelo de Claro